drugset / Trial / NCT01967329
CANHelp Working Group Treatment Trials
Phase 4
Completed
338 enrolled
University of Alberta
Alberta Innovates Health Solutions · collabArcticNet · collabCanadian Institutes of Health Research (CIHR) · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The CANHelp Working Group Treatment Trials are part of a comprehensive research program carried out by the Canadian North Helicobacter pylori (CANHelp) Working Group. The treatment component involves a series of community-specific trials designed with community input and varying on the specific treatment regimens and number of treatment arms among other study details.
Timeline
- Start
- 2008-11
- Primary completion
- 2019-05
- Completion
- 2019-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 1 g | Oral |
| Comparator | Bismuth subsalicylate | Small molecule | 2 unknown | Oral |
| Comparator | Clarithromycin | Small molecule | 500 mg | Oral |
| Comparator | Metronidazole | Small molecule | 500 mg | Oral |
| Comparator | Rabeprazole | Small molecule | 20 mg | Oral |
| Comparator | Tetracycline | Unknown | 500 mg | Oral |